Versant Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175K Buy
626
+8
+1% +$2.1K 0.02% 681
2026
Q1
$165K Sell
618
-182
-23% -$49.3K 0.02% 661
2025
Q4
$201K Buy
800
+573
+252% +$152K 0.03% 492
2025
Q3
$65.2K Buy
227
+3
+1% +$804 0.01% 906
2025
Q2
$58.8K Buy
224
+9
+4% +$2.19K 0.01% 901
2025
Q1
$50K Buy
215
+8
+4% +$1.94K 0.01% 863
2024
Q4
$47.5K Buy
207
+191
+1,194% +$43.8K 0.01% 600
2024
Q3
$3.58K Hold
16
﹤0.01% 1391
2024
Q2
$3.26K Sell
16
-9
-36% -$1.83K ﹤0.01% 1356
2024
Q1
$5.46K Hold
25
﹤0.01% 996
2023
Q4
$5.68K Buy
25
+1
+4% +$210 ﹤0.01% 927
2023
Q3
$4.83K Sell
24
-4
-14% -$844 ﹤0.01% 992
2023
Q2
$5.79K Buy
28
+5
+22% +$970 ﹤0.01% 983
2023
Q1
$4.58K Hold
23
﹤0.01% 970
2022
Q4
$4.71K Hold
23
﹤0.01% 912
2022
Q3
$4K Buy
23
+1
+5% +$205 ﹤0.01% 905
2022
Q2
$4K Hold
22
﹤0.01% 920
2022
Q1
$5K Hold
22
﹤0.01% 884
2021
Q4
$6K Hold
22
﹤0.01% 847
2021
Q3
$5K Hold
22
﹤0.01% 888
2021
Q2
$5K Sell
22
-48
-69% -$10.9K ﹤0.01% 905
2021
Q1
$15K Sell
70
-4
-5% -$803 0.01% 647
2020
Q4
$13K Hold
74
0.01% 654
2020
Q3
$12K Hold
74
0.01% 597
2020
Q2
$10K Hold
74
﹤0.01% 622
2020
Q1
$8K Buy
74
+4
+6% +$576 ﹤0.01% 622
2019
Q4
$10K Sell
70
-16
-19% -$2.31K 0.01% 700
2019
Q3
$12K Hold
86
0.01% 641
2019
Q2
$12K Sell
86
-33
-28% -$4.61K 0.01% 664
2019
Q1
$15K Sell
119
-3
-2% -$370 0.01% 754
2018
Q4
$13K Hold
122
0.01% 717
2018
Q3
$18K Sell
122
-22
-15% -$3.35K 0.01% 687
2018
Q2
$22K Hold
144
0.01% 578
2018
Q1
$20K Sell
144
-18
-11% -$2.64K 0.01% 627
2017
Q4
$22K Hold
162
0.01% 615
2017
Q3
$20K Hold
162
0.01% 589
2017
Q2
$21K Sell
162
-4
-2% -$490 0.01% 576
2017
Q1
$20K Hold
166
0.01% 584
2016
Q4
$18K Sell
166
-35
-17% -$3.89K 0.01% 629
2016
Q3
$23K Sell
201
-5
-2% -$589 0.01% 516
2016
Q2
$23K Sell
206
-1
-0.5% -$108 0.01% 495
2016
Q1
$20K Sell
207
-15
-7% -$1.44K 0.01% 515
2015
Q4
$23K Buy
+222
New +$22.9K 0.01% 453

Other funds holding LH

Versant Capital Management's LH Position: Q2 2026 in Review

Versant Capital Management increased its Labcorp (LH) stake by 1.3% in Q2 2026, buying an estimated $2.1K and bringing the position to 626 shares worth $175K. The position accounts for 0.02% of the portfolio, ranked #681.

Versant Capital Management first reported a position in LH in Q4 2015 and has held it in 43 quarters since. The position peaked at $201K in Q4 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Versant Capital Management held 626 shares of Labcorp worth $175K as of Q2 2026.
  • Versant Capital Management bought 8 Labcorp shares in Q2 2026, an estimated $2.1K.
  • Labcorp made up 0.02% of Versant Capital Management's portfolio in Q2 2026, its #681 holding.
  • Versant Capital Management first reported a position in Labcorp in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's Labcorp position peaked at $201K in Q4 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.